Man et al., 2020 - Google Patents
Microfluidic assessment of red blood cell mediated microvascular occlusionMan et al., 2020
View PDF- Document ID
- 10747003273300180534
- Author
- Man Y
- Kucukal E
- An R
- Watson Q
- Bosch J
- Zimmerman P
- Little J
- Gurkan U
- Publication year
- Publication venue
- Lab on a Chip
External Links
Snippet
Abnormal red blood cell (RBC) deformability contributes to hemolysis, thrombophilia, inflammation, and microvascular occlusion in various circulatory diseases. A quantitative and objective assessment of microvascular occlusion mediated by RBCs with abnormal …
- 210000003324 RBC 0 title abstract description 206
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Man et al. | Microfluidic assessment of red blood cell mediated microvascular occlusion | |
| Qiu et al. | Microvasculature-on-a-chip for the long-term study of endothelial barrier dysfunction and microvascular obstruction in disease | |
| JP6138874B2 (en) | Microfluidic sorting device for detecting and isolating cells | |
| Shevkoplyas et al. | Direct measurement of the impact of impaired erythrocyte deformability on microvascular network perfusion in a microfluidic device | |
| Lugo-Cintrón et al. | Matrix density drives 3D organotypic lymphatic vessel activation in a microfluidic model of the breast tumor microenvironment | |
| Sosa et al. | The relationship between red blood cell deformability metrics and perfusion of an artificial microvascular network | |
| Iragorri et al. | A microfluidic approach to study the effect of mechanical stress on erythrocytes in sickle cell disease | |
| EP3452221B1 (en) | Microfluidic neutrophil assays and systems for disease detection | |
| Tay et al. | A novel microdevice for rapid neutrophil purification and phenotyping in type 2 diabetes mellitus | |
| US11460465B2 (en) | Cell chemotaxis assays | |
| Duez et al. | Splenic retention of Plasmodium falciparum gametocytes to block the transmission of malaria | |
| Man et al. | Standardized microfluidic assessment of red blood cell–mediated microcapillary occlusion: Association with clinical phenotype and hydroxyurea responsiveness in sickle cell disease | |
| Jones et al. | Microfluidic platform for measuring neutrophil chemotaxis from unprocessed whole blood | |
| KR20200131837A (en) | How to use circulating cells to monitor treatment response and disease progression in a subject | |
| Man et al. | OcclusionChip: a functional microcapillary occlusion assay complementary to ektacytometry for detection of small-fraction red blood cells with abnormal deformability | |
| EP2300820A2 (en) | Method for screening compounds for their ability to increase rigidity of red blood cells infected by a protozoan parasite of the genus plasmodium, method for filtering red blood cells, and application thereof. | |
| Wu et al. | Exploring inflammatory disease drug effects on neutrophil function | |
| CN106110425B (en) | AIDS plasma purification therapeutic equipment | |
| US20140295483A1 (en) | Apparatus and method for in-vitro drug screening for cancer metastasis | |
| Man | Biomimetic Microfluidic Platforms for Assessing Red Blood Cell Deformability and Microvascular Occlusion | |
| CN106178163A (en) | Acquired immune deficiency syndrome (AIDS) biological cell immunization therapy instrument | |
| KR20210057639A (en) | An microfluidic device for separating bacteria in blood | |
| Man et al. | Microfluidic concurrent assessment of red blood cell adhesion and microcapillary occlusion: potential hemorheological biomarkers in sickle cell disease | |
| Lu | Parylene as a new membrane material for biomems applications | |
| CN106178162A (en) | Treating AIDS organelle |